Related Experiment Video
Updated: Apr 29, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing
Weidong Li1, Xuejun Jin1, Xubin Deng1
1Department of Medical Oncology, Affiliated Cancer Hospital of Guangzhou Medical University, Cancer Center of Guangzhou Medical University (CCGMU), Guangzhou, People's Republic of China.
Abstract:
Accumulating evidence has shown that microRNAs are involved in multiple processes in gastric cancer (GC) development and progression. Aberrant expression of miR-497 has been frequently reported in cancer studies; however, the role and mechanism of its function in GC remains unknown. Here, we reported that miR-497 was frequently downregulated in GC tissues and associated with aggressive clinicopathological features of GC patients. Further in vitro observations showed that the enforced expression of miR-497 inhibited cell proliferation by blocking the G1/S transition and decreased the invasion of GC cells, implying that miR-497 functions as a tumor suppressor in the progression of GC. In vivo study indicated that restoration of miR-497 inhibited tumor growth and metastasis. Luciferase assays revealed that miR-497 inhibited eIF4E expression by targeting the binding sites in the 3'-untranslated region of eIF4E mRNA. qRT-PCR and Western blot assays verified that miR-497 reduced eIF4E expression at both the mRNA and protein levels. A reverse correlation between miR-497 and eIF4E expression was noted in GC tissues. Taken together, our results identify a crucial tumor suppressive role of miR-497 in the progression of GC and suggest that miR-497 might be an anticancer therapeutic target for GC patients.
Insights
MicroRNA-497 (miR-497) acts as a tumor suppressor in gastric cancer (GC) by inhibiting cell proliferation and invasion. Restoring miR-497 levels may offer a new therapeutic strategy for GC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) play critical roles in gastric cancer (GC) pathogenesis.
- The specific function of miR-497 in GC development and its underlying mechanisms are not well understood.
Purpose of the Study:
- To investigate the role and mechanism of miR-497 in gastric cancer progression.
- To determine if miR-497 functions as a tumor suppressor or oncogene in GC.
Main Methods:
- Analysis of miR-497 expression in GC tissues and correlation with clinicopathological features.
- In vitro studies assessing the effects of miR-497 on GC cell proliferation and invasion.
- In vivo experiments to evaluate the impact of miR-497 on tumor growth and metastasis.
- Luciferase assays, qRT-PCR, and Western blot to identify and validate miR-497 targets.
Main Results:
- miR-497 was frequently downregulated in GC tissues and associated with aggressive features.
- Enforced miR-497 expression inhibited GC cell proliferation (G1/S transition block) and invasion.
- Restoration of miR-497 suppressed tumor growth and metastasis in vivo.
- miR-497 directly targeted and inhibited eukaryotic translation initiation factor 4E (eIF4E) expression at mRNA and protein levels.
- A negative correlation between miR-497 and eIF4E expression was observed in GC tissues.
Conclusions:
- miR-497 functions as a tumor suppressor in gastric cancer progression.
- miR-497 inhibits GC by downregulating eIF4E.
- miR-497 represents a potential therapeutic target for gastric cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Abnormal Proliferation
Experimental RNAi

